Cita APA

Cuchacovich, M., Soto, L., Edwardes, M., Gutierrez, M., Llanos, C., Pacheco, D., . . . Valenzuela, O. (2006). Tumour necrosis factor (tnf)alpha-308 g/g promoter polymorphism and tnf alpha levels correlate with a better response to adalimumab in patients with rheumatoid arthritis.

Citación estilo Chicago

Cuchacovich, M., et al. Tumour Necrosis Factor (tnf)alpha-308 G/g Promoter Polymorphism and Tnf Alpha Levels Correlate With a Better Response to Adalimumab in Patients With Rheumatoid Arthritis. 2006.

Cita MLA

Cuchacovich, M., et al. Tumour Necrosis Factor (tnf)alpha-308 G/g Promoter Polymorphism and Tnf Alpha Levels Correlate With a Better Response to Adalimumab in Patients With Rheumatoid Arthritis. 2006.